Gilead Sciences (GILD) revenue: $29.4B
Gilead Sciences reported $29.4B of revenue for the year ended Dec 31, 2025, up 2.4% from $28.8B a year earlier.
From Gilead Sciences's filings with the SEC · Read the filing · GILD stock page
Gilead Sciences revenue by year
#148 of 3,623 US companies by revenue · See the full ranking
| Year ended | Revenue | Change |
|---|---|---|
| Dec 31, 2025 | $29.4B | +2% |
| Dec 31, 2024 | $28.8B | +6% |
| Dec 31, 2023 | $27.1B | -1% |
| Dec 31, 2022 | $27.3B | -0% |
| Dec 31, 2021 | $27.3B | – |
Revenue of similar companies
Companies in the same industry as Gilead Sciences, by SEC industry code, with the closest revenue. Each name opens the same page for that company.
Questions and answers
What is Gilead Sciences's revenue?
Gilead Sciences reported $29.4B of revenue for the year ended Dec 31, 2025, up 2.4% from $28.8B a year earlier.
Numbers as reported in Gilead Sciences's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology